Opinion
Video
Author(s):
A panelist discusses how benign prostatic hyperplasia (BPH) treatment has evolved to include a spectrum of minimally invasive and surgical interventions, ranging from emerging technologies like prostatic urethral lift (PUL) and water vapor thermal therapy (WVTT) to more established resective surgical techniques such as transurethral resection of the prostate (TURP), holmium laser enucleation (HoLEP), Aquablation, and Greenlight XPS, providing urologists with a diverse array of options tailored to individual patient characteristics, prostate size, and specific clinical needs.
Video content above is prompted by the following:
Overview
Management of BPH encompasses a spectrum of interventions ranging from minimally invasive procedures to more extensive surgical techniques. Physicians should consider patient-specific factors such as prostate size, symptom severity, comorbidities, and patient preferences when selecting an appropriate treatment approach.
Minimally Invasive Procedures
Minimally invasive treatments offer reduced procedural risks and faster recovery compared with traditional surgical interventions:
Key Modalities
Resective Surgical Procedures
More comprehensive interventions for significant BPH cases:
Established Techniques
Clinical Considerations
Conclusion
The evolving landscape of BPH treatments offers physicians multiple options to address patient needs, balancing efficacy, safety, and quality-of-life considerations.